Read + Share
Amedeo Smart
Independent Medical Education
Nieder C, Aanes SG, Haukland EC. Survival and Early Death Within Three Months from the Start of Immune Checkpoint Inhibitors in Patients With Different Types of Cancer. Anticancer Res 2022;42:3061-3066.PMID: 35641252
Email
LinkedIn
Facebook
Twitter
Privacy Policy